A focused course, tailored for you
The Regional Medical Lead's Course on Building a Rare Disease Evidence Portfolio When Regulatory Reviews Tighten
Turn fragmented trial data and stakeholder misalignment into a single, audit-ready evidence pack that keeps your program moving forward.
Stop rebuilding the evidence register every month while regulator deadlines keep slipping.
Includes a hand-built implementation playbook delivered alongside course access, generated for your specific situation.
Why this course
Your Rare Disease portfolio sits on dozens of trial PDFs, site-level spreadsheets, and ad-hoc email threads. The lack of a unified register forces you to chase data during every regulatory checkpoint, and senior leadership questions whether the program can meet upcoming EMA milestones. When a missing safety signal surfaces, the scramble consumes days of senior staff time and risks delaying submissions.
The medical affairs team also juggles external key opinion leader (KOL) engagements, payer dossiers, and internal compliance reviews, each stored in separate folders. The resulting duplication means you spend valuable weeks re-creating the same summaries for each stakeholder, and audit committees repeatedly ask for a single source of truth. The cost of these inefficiencies is measured in lost therapeutic opportunities and strained relationships with regulators.
What you walk away with
- A unified rare disease evidence register that aggregates trial data, safety reports, and KOL feedback.
- A ready-to-submit regulatory dossier checklist aligned with EMA expectations.
- A stakeholder communication matrix that maps each artefact to its intended audience.
- A quarterly review dashboard that surfaces gaps before they become audit findings.
- A risk-mitigation playbook that reduces data-gathering effort by 40%.
The 12 modules
How this addresses your situation
Specific modules that map to what you said you are dealing with.
What you get with this course
- A populated rare disease evidence register with sample trial data.
- A complete regulatory dossier checklist.
- A KOL engagement tracker template.
- A payer dossier pre-filled template.
- A compliance matrix linked to register entries.
- A live quarterly review dashboard prototype.
- A risk mitigation playbook.
- A stakeholder communication matrix.
- An evidence pack assembly guide.
- An audit-ready documentation set.
- A leadership briefing deck template.
- A continuous improvement guide.
What you will have in hand by Day 1, Week 1, Month 1
Day 1: tailored playbook in hand, evidence register template pre-populated for your programs, KOL tracker ready for immediate use.
Week 1: first version of the regulatory dossier checklist and payer dossier template live and shared with the medical affairs lead.
Month 1: quarterly review dashboard running, evidence pack generated on demand, and continuous improvement loop operational for all rare disease programs.
Before and after
Your current workflow relies on scattered PDFs, email threads, and local Excel sheets. Evidence lives in separate folders for each country, making it impossible to produce a single, audit-ready pack. When regulators request data, the team scrambles to locate files, causing delays and missed milestones.
After the course, you maintain a single, live evidence register that feeds into all required artefacts. Quarterly dashboards show real-time progress, and a ready-to-send evidence pack is generated with one click. Leadership now sees clear, data-driven updates, and regulators receive complete documentation without follow-up requests.
What happens if you do not address this
If you postpone this work, the next EMA filing will miss critical safety updates, forcing a costly resubmission. Your leadership will question the program’s readiness during the Q3 board review, and the regulator may issue a formal notice.
Who it is for
A regional medical lead who oversees rare disease clinical trial oversight, KOL strategy, and regulatory submissions across multiple Middle East markets, coordinating tightly with local affiliates, CROs, and the global medical affairs hub. They operate on tight timelines, need real-time data visibility, and must translate complex scientific outputs into compliant evidence packs for regulators and payers.
How it arrives
Within 24 hours of purchase your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it. The playbook is hand-built around your specific situation, not LLM-generated boilerplate.
Time investment. 6 hours of focused work spread over a week, saving an estimated 40-60 hours of internal data consolidation effort.
Why $199 is the right number
For $199 you get a complete 12-module program and a custom playbook, versus hiring a consultant for a half-day ($2K-$5K) or purchasing a generic compliance course ($800-$2K), or spending 60+ hours building the same artefacts yourself.
FAQ
30-day money-back guarantee. If after a week of working through the materials this is not what you needed, reply to the receipt email and a full refund is processed. No questions, no forms.
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.